bpc-157 tb-500 5mg 5mg (5mg) + (5mg) + KPV (10mg) + GHK-Cu (5mg) BPC-157 + TB-500 Blend 5mg/5mg

Loss or mutation of phosphatase and tensin homolog ( PTEN ) and mutation or overactivation of phosphatidylinositol 3-kinase ( PI3K ) occur in high frequency across many cancers 6

Mechanisms of Action Although human clinical data is limited, preclinical research suggests BPC157 may: Accelerate tissue repair through increased angiogenesis, improved cell migration, and enhanced growth factor activity

Arch Osteoporos

Regulatory and legal status FDA classification As of April 2026, BPC-157 is a Category 2 bulk drug substance under FDA's framework for compounding under Section 503A

This is because vitamin B12 is primarily in animal-based foods

Predrag Sikiri, Sven Seiwerth, Ruman, R., Branko Turkovi, Dinko Stani Rokotov, Luka Bri, Sever, M., Kliek, R., Boo Radi, Domagoj Drmi, Spomenko Ili, Kolenc, D., Gorana Aralica, Safic, H., Jelena uran, Rak, D., Senka Didi, Hrvoje Vri, & Boidar ebei